The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Factor Bioscience is building the future of regenerative medicine by targeting and repairing the molecular origins of disease. Factor Bioscience was established to explore new methods for controlling gene expression and cell fate. Their scientists developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state, a key invention now recognized by several patents. This technology, which enables the production of patient-specific cells for transplantation, has wide-ranging applications in personalized regenerative medicine.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Icon Genetics GmbH develops biopharmaceuticals and protein products using plants. Its product candidates, engineered organisms, and technology platforms for plant biotechnology, and plant-based production. The firm develops generation production platforms and product prototypes for pharmaceutical, agricultural, animal health, and chemical biotech markets. The company was founded by Yuri Gleba, Newell Bascomb, and Hans-Ulrich Koop in 2000 and is headquartered in Halle, Germany.

Diamidex SAS provides research and development services in biotechnology. The company was founded by Sam Dukan in June 2019 and is headquartered in Marseille, France.

Tosk Incorporated is a biopharmaceutical company dedicated to improving the safety and efficacy of drugs for debilitating and life-threatening diseases such as cancer, arthritis, and psoriasis. Side effects limit the use and effectiveness of many of today's pharmaceutical products. Tosk employs proprietary methods to discover and develop new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. This approach not only improves upon proven treatment regimens but also has the potential to deliver these enhanced drugs to the medical community more quickly and with lower research and development costs than is typically required for an entirely new drug.

PrimaGen Holding BV designs and develops molecular diagnostic tests. The firm conducts tests in the fields of mitochondrial toxicity, drug development toxicology screening, HIV monitoring, DFS paper technology, oncology and virus discovery. It also develops in monitoring toxic side effects of antiviral medication and for diagnosing and monitoring certain forms of cancer. The company was founded in November 2001 and is headquartered in Amsterdam, the Netherlands.

Established in 1998, Union Biometrica is the pioneer in the development, manufacture, distribution and service of high throughput systems for the screening of "large" (10-1500 micron) particles These systems can analyze sort and dispense objects that are too large or too fragile for traditional flow cytometers. Typical samples include: - Delicate large cells / cell clusters such as adipocytes, embryoid bodies, pancreatic islets, duct cells and hepatocytes - Viable small multi-cellular model organisms like C.elegans, D. melanogaster and D. rerio - Beads (cells growing in or on beads, bead-based libraries) - Seeds (Arabidopsis, tobacco), pollen and certain types of fungi (Aspergillus)

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Probiotical SpA manufactures probiotic lactic ferments. It offers probiotics, healthcare, food supplements, LBPs, pharma, synbiotics, medical devices, and clinical studies. The company was founded in 1985 and is headquartered in Novara, Italy.

Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications. The company's product development portfolio includes MultiStem, a stem cell product, that is being developed as a treatment for multiple disease indications, is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, Athersys develops pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy, or other forms of excessive daytime sleepiness.

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer. The company’s portfolio includes several lines of proprietary chimeric antigen receptor T-cells targeting individual cancers. Its lead product candidate is UCART19, an engineered T-cell product candidate for the treatment of CD19 expressing hematologic malignancies that developed in acute lymphoblastic leukemia and chronic lymphocytic leukemia. The company’s products also include UCART123 for acute myeloid leukemia indications, and UCART38 and UCARTCS1 for multiple myeloma indications.

AgResearch offers world-class expertise across a range of science areas. AgResearch is the Crown Research Institute tasked with delivering leading agricultural science and innovation to benefit the wider New Zealand economy. Our internationally-recognised scientists work across the agricultural sectors in collaboration with a range of stakeholders both nationally and internationally, putting science and innovation at the forefront.

SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia.

Glycom is a Danish company with more than 150 employees that pioneered the development and commercialization of HMOs for Early Life Nutrition applications. The company operates a state-of-the-art manufacturing plant in Esbjerg (Denmark) and is the only fully-integrated HMO provider in the world with its own product development, preclinical and clinical development, regulatory and large-scale production with an exciting innovation roadmap for next-generation HMOs.

Purac Biochem BV (doing business as Purac), part of Corbion NV, is a company headquartered in Gorinchem, the Netherlands. The firm develops and manufactures food preservatives, biobased chemicals and biopplastics.

TNO is an independent research organization with approximately 3,000 employees. They believe in joint creation of value in social and economic terms. They focus on transitions or changes in five social themes: Industry, Healthy Living, Defense & Safety, Environment and Energy. Targeted innovation, which is what TNO stands. They develop knowledge not about knowledge, but about practical application.

Xiamen Innovax Biotech Co., Ltd. manufactures vaccines and diagnostic reagents. It focuses on research and development, manufacturing, marketing of vaccine, diagnosis kit and medical equipment. The company was founded in 2005 and is headquartered in Xiamen, China.